BVF II GP LLC
SEC CIK 1803806 · EDGAR
BoughtSold
Most active insiders at KYMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Booth Bruce | Dir | — | $226.03M |
| 2 | BVF PARTNERS L P/IL | Dir, See Remarks, Footnotes | — | $173.67M |
| 3 | BAKER FELIX | Dir, 10% | $172.50M | — |
| 4 | Mainolfi Nello | CEO, Dir | — | $33.41M |
| 5 | Chadwick Jeremy G | COO | — | $15.60M |
| 6 | Jacobs Bruce N. | CFO | — | $9.96M |
| 7 | Gollob Jared | Chief Medical Off | — | $9.13M |
| 8 | Esposito Pamela | Dir | — | $3.05M |
| 9 | Goodman Noah | Chief Business Off | — | $2.22M |
| 10 | Ridloff Elena | Dir | — | $1.29M |
BVF II GP LLC made no open-market trades at KYMR in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-11-06 | 2023-11-02+ | KYMR | Kymera Therapeutics, Inc. | BVF II GP LLC | Dir, See Remarks, Footnotes | P - Purchase | $12.80 | +414.1K | 284.5K | New | +$5.30M |
| DM | 2023-01-19 | 2023-01-19 | CGEM | Cullinan Therapeutics, Inc. | BVF II GP LLC | See Explanation of Responses | J - Other | — | -6.40M | 558.9K | -92% | — |
| M | 2022-04-05 | 2022-04-01 | CGEM | Cullinan Therapeutics, Inc. | BVF II GP LLC | See Explanation of Responses | P - Purchase | $10.75 | +276.0K | 3.06M | +10% | +$2.97M |
Purchase Sale Sale after option exercise All abbreviations